Ralph Hirschfeld
Family · Putnam, CTNPI 1144523077
Payments from drug & device makers
Across 1,349 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Supernus Pharmaceuticals, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $13K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 195 | $3,396 |
| AbbVie | 130 | $2,259 |
| Teva Pharmaceuticals USA, Inc. | 97 | $2,104 |
| Supernus Pharmaceuticals, Inc. | 99 | $2,089 |
| Neurocrine Biosciences, Inc. | 102 | $1,908 |
| Takeda Pharmaceuticals U.S.A., Inc. | 85 | $1,703 |
| Axsome Therapeutics, Inc. | 84 | $1,633 |
| Otsuka America Pharmaceutical, Inc. | 66 | $1,611 |
| Alkermes, Inc. | 79 | $1,351 |
| Corium, LLC | 81 | $1,325 |
| Vanda Pharmaceuticals Inc. | 58 | $1,315 |
| Johnson & Johnson | 39 | $1,207 |
| Lundbeck LLC | 59 | $1,110 |
| E.r. Squibb & Sons, L.L.C. | 60 | $958 |
| Sunovion Pharmaceuticals Inc. | 37 | $720 |
| Tris Pharma Inc | 18 | $358 |
| Indivior Inc. | 18 | $352 |
| Idorsia Pharmaceuticals US Inc | 12 | $197 |
| Collegium Pharmaceutical, Inc. | 10 | $176 |
| Merck | 8 | $146 |
| Bausch Health US, LLC | 5 | $94 |
| Almatica Pharma LLC | 4 | $78 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $14 |
How this compares
$26,143 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Putnam
- Sara Garcia-GomesPutnam$19K
- Erin GouldsbroughPutnam$12K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.